Functional Technologies Reports Increase in Non-Brokered Private Placement

Functional Technologies Corp. (TSX VENTURE:FEB)(OTCQX:FEBTF) (the "Company")
reports that, subject to TSX Venture Exchange approval, the amount to be raised
in the second tranche of the non-brokered private placement announced in its
news release of July 16, 2012 has been further increased to $1,500,000. Details
of the closing of the first tranche were reported in the Company's news release
of August 9, 2012. 


About Functional Technologies Corp. 

Functional Technologies develops and commercializes proprietary, advanced
yeast-based solutions to significant challenges in the food, beverage and
healthcare industries. The Company's platform improves the performance of innate
yeast functions, and prevents the formation of naturally occurring toxins and
contaminants that either affect final product quality or are classified by the
World Health Organization ("WHO") as probable human carcinogens. Functional
Technologies' lead technologies include yeasts that prevent and reduce the
formation of foul-smelling hydrogen sulphide (H2S) and the WHO classified
probable carcinogen, acrylamide - both by-products of food and beverage
processing. These contaminants are found in many commonly consumed items, such
as fermented food products and alcoholic beverages, and baked and fried foods.
For more information, please visit our website at www.functionaltechcorp.com.